valine has been researched along with Recrudescence in 167 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (11.38) | 18.2507 |
| 2000's | 67 (40.12) | 29.6817 |
| 2010's | 78 (46.71) | 24.3611 |
| 2020's | 3 (1.80) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gu, S; Li, L; Lv, L; Quan, J; Wu, Z; Xu, Q; Zhang, S; Zheng, B | 1 |
| Arai, J; Fukumura, Y; Imai, M; Kato, J; Kojima, K; Kondo, M; Kurokawa, K; Mori, M; Ohki, T; Seki, M; Shibata, C; Tagawa, K; Takagi, K; Toda, N | 1 |
| Bittar, C; Chen, S; Fernandes Campos, GR; Harris, M; Martinelli, ALC; Pereira, LRL; Rahal, P; Souza, FF; Vilela Rodrigues, JP; Ward, J | 1 |
| Chevaliez, S; Fourati, S; François, M; Hézode, C; Mallat, A; Pawlotsky, JM; Roudot-Thoraval, F; Ruiz, I; Scoazec, G; Soulier, A; Varaut, A | 1 |
| Galen, BT; Rosenberg, J | 1 |
| Bañares, R; Casafont, F; Castellote, J; Castells, L; Cuervas-Mons, V; Espinosa, MD; Fernández, I; García-Gonzalez, M; González, A; González-Diéguez, L; Herrero, JI; Llaneras, J; Londoño, MC; Lorente, S; Molina Pérez, E; Montero Alvarez, JL; Narváez, I; Otero, A; Pascasio, JM; Pascual, S; Pons, JA; Prieto, M; Salcedo, M; Sánchez-Antolín, G; Sousa, JM; Testillano, M; Vinaixa, C | 1 |
| Akamatsu, N; Eguchi, S; Furukawa, H; Goto, R; Honda, M; Ikegami, T; Inomata, Y; Ishiyama, K; Kitagawa, Y; Kokudo, N; Ku, Y; Kuramitsu, K; Maehara, Y; Ohdan, H; Okajima, H; Shimada, M; Shinoda, M; Soyama, A; Taketomi, A; Ueda, Y; Uemoto, S; Yanaga, K; Yoshizumi, T | 1 |
| Agut, H; Bodaghi, B; Bourcier, T; Boutolleau, D; Burrel, S; Chiquet, C; Colin, J; Deback, C; Gueudry, J; Labetoulle, M; M'Garrech, M; Rousseau, A; Titier, K; Weber, M | 1 |
| Eurich, D; Globke, B; Pratschke, J; Schott, E; Teegen, EM | 1 |
| Angelico, M; Biolato, M; Calvaruso, V; Carrai, P; Craxì, A; D'offizi, G; Fagiuoli, S; Guaraldi, G; Lenci, I; Lionetti, R; Loiacono, L; Mancusi, RL; Mazzarelli, C; Milana, M; Montalbano, M; Piccolo, P; Valente, G; Visco-Comandini, U | 1 |
| Al-Zoairy, R; Beinhardt, S; Ferenci, P; Graziadei, I; Hofer, H; Kozbial, K; Maieron, A; Rasoul-Rockenschaub, S; Stättermayer, AF; Stauber, R; Strasser, M; Trauner, M; Zoller, H | 1 |
| Hidaka, H; Inoue, T; Koizumi, W; Kubota, K; Murakami, S; Nakatani, S; Nakazawa, T; Shibuya, A; Takeuchi, A; Tanaka, Y; Uojima, H; Yamane, K | 1 |
| Roberts, RA | 1 |
| Caroprese, M; Coppola, N; De Pascalis, S; Guerrera, B; Iovinella, V; Macera, M; Masarone, M; Minichini, C; Occhiello, L; Starace, M; Vitrone, M | 1 |
| Alcaro, S; Artese, A; Barreca, GS; De Siena, M; Di Salvo, S; Fabiani, F; Focà, A; Giancotti, F; Gravina, T; Liberto, MC; Marano, V; Marascio, N; Pavia, G; Perrotti, N; Reale, M; Romeo, I; Talarico, C; Torti, C | 1 |
| Bandeira de Mello Brandao, A; Costabeber, AM; Cracco Cantisani, GP; Kiss, G; Leipnitz, I; Marroni, CA; Martini, J; Medeiros Fleck, A; Meine, MH; Mucenic, M; Sacco, FKF; Soares Schlindwein, E; Zanotelli, ML | 1 |
| Goto, H; Hattori, M; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Ishizu, Y; Katano, Y; Kumada, T; Kuzuya, T; Toyoda, H | 1 |
| Bacca, D; Cenderello, G; Copetti, M; De Stefano, G; Losappio, R; Mangia, A; Mazzola, M; Minerva, N; Palmieri, V; Piazzola, V; Potenza, D; Santoro, R; Sogari, F; Terreni, N | 1 |
| Fukuhara, T; Furusho, N; Harada, N; Ikegami, T; Itoh, S; Kato, M; Maehara, Y; Shimoda, S; Soejima, Y; Yoshizumi, T | 1 |
| Jung, BH; Lee, SG; Park, JI | 1 |
| Khan, AJ; Mohindra, S; Negi, TS; Parmar, D; Ranjan, P; Saraswat, VA | 1 |
| Chen, JH; Dong, B; Jiang, JD; Li, H; Li, JR; Liu, NN; Lv, XQ; Peng, ZG; Tan, JL; Zou, LL | 1 |
| Ataíde, EC; Boin, IFSF; Santos, AG; Stucchi, RSB; Zanaga, LP | 1 |
| Barlera, S; Cappellini, G; Cosmi, F; Disertori, M; Fabbri, G; Favero, C; Franzosi, MG; Latini, R; Maggioni, AP; Moroni, LA; Quintarelli, S; Staszewsky, L | 1 |
| Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA; Symonds, WT | 1 |
| Aldazabal, M; Arruti, M; Blanco, A; González, F; López de Munain, A; Piñeiro, L; Zapico, MS | 1 |
| Skinnider, B; Villa, D | 1 |
| Kinghorn, GR; Magaret, A; Mark, KE; Meng, TC; Sacks, SL; Selke, S; Slade, HB; Spruance, S; Wald, A | 1 |
| Califf, RM; Kober, L; Lewis, EF; Li, Y; Pfeffer, MA; Reed, SD; Rouleau, JL; Schulman, KA; Solomon, SD; Velazquez, EJ; Weinfurt, KP; White, HD | 1 |
| Agarwal, K; Berg, T; Bernstein, B; Campbell, AL; Collins, CA; Da Silva-Tillmann, B; Forns, X; Hezode, C; Kowdley, KV; Lovell, SS; Podsadecki, T; Poordad, F; Shiffman, ML; Trinh, R; Wedemeyer, H; Yoshida, EM; Zeuzem, S | 1 |
| Grillo, E; Jaén Olasolo, P; Jiménez Gómez, N; Martínez, MA | 1 |
| Baruch, Y; Bernstein, D; Bhandari, BR; Box, TD; Caruntu, FA; Chulanov, V; Cohen, D; Cooper, C; Enayati, P; Ferenci, P; Gervain, J; Green, S; Hassanein, T; Janczewska, E; King, M; Lalezari, J; Luo, Y; Marinho, RT; Moreno, C; Nyberg, A; Planas, R; Podsadecki, T; Reddy, KR; Rizzardini, G; Sepe, T; Tam, E; Tsai, N; Xie, W; Younes, Z | 1 |
| Mizuta, I; Nakagawa, M; Noto, Y; Sasaki, R; Shiga, K; Yamawaki, M | 1 |
| Andreoli, A; Angelico, M; D'Offizi, G; Durand, C; Ferenci, P; Knop, V; Lenci, I; Lionetti, R; Montalbano, M; Pellicelli, AM; Telese, A; Zeuzem, S | 1 |
| Chosidow, O; Do, G; Le Cleach, L; Lebrun-Vignes, B; Maruani, A; Ravaud, P; Trinquart, L | 1 |
| Agarwal, K; Cohen, D; Podsadecki, T; Poordad, F; Xie, W; Younes, Z | 1 |
| Firpi, RJ; Hilgenfeldt, E | 1 |
| Pinder, M; Wright, A | 1 |
| Coilly, A; Duclos-Vallée, JC; Roche, B; Samuel, D | 1 |
| Arain, MA; Arain, N; Paravastu, SC | 1 |
| Achterfeld, A; Canbay, A; Gerken, G; Herzer, K; Papadopoulos-Köhn, A; Paul, A; Timm, J; Walker, A | 1 |
| Dusheiko, G; Kalafateli, M; Manousou, P | 1 |
| Akarca, US; Hall, C; Hézode, C; Lawitz, E; Makara, M; Mobashery, N; Morillas, RM; Pilot-Matias, T; Preotescu, LL; Redman, R; Thuluvath, PJ; Varunok, P; Vilchez, RA | 1 |
| Fernández Fournier, M; Gómez Fernández, C; González Ramos, J; Herranz Pinto, P; Mayor Ibarguren, A; Romero Gómez, MP; Tallón Barranco, A | 1 |
| Chmielik, E; Czarniecka, A; Handkiewicz-Junak, D; Jarzab, B; Jarzab, M; Kowal, M; Krajewska, J; Lange, D; Maciejewski, A; Oczko-Wojciechowska, M; Poltorak, S; Rusinek, D; Sacher, A; Stobiecka, E; Zebracka-Gala, J; Zembala-Nozynska, E | 1 |
| Ueda, Y; Uemoto, S | 1 |
| Chmieliauskaite, M; Houston, AM; Sollecito, TP; Stoopler, ET | 1 |
| Antinori, S; Calvi, E; Milazzo, L; Regalia, E; Sollima, S; Torre, A | 1 |
| Gonzalez, YS; Huber, C; Juday, T; Saab, S; Wang, A | 1 |
| Fontana, RJ; Hughes, EA; Landis, C; McPhee, F; Noviello, S; Poordad, F; Schiff, ER; Swenson, ES; Vierling, JM; Yang, R | 1 |
| Bahirwani, R; Berg, C; Brown, RS; Castells, L; Chacko, KR; Durand, CM; ElSharkawy, AM; Emond, B; Ferenci, P; Fontana, RJ; Herzer, K; Ionescu-Ittu, R; Jafri, SM; Joshi, S; Knop, V; Lionetti, R; Loiacono, L; Londoño, MC; Montalbano, M; Moreno-Zamora, A; Mubarak, A; Pellicelli, AM; Prieto, M; Reddy, KR; Stadler, B; Stauber, RE; Stenmark, S; Torti, C; Vekeman, F; Weiland, O | 1 |
| Baños, I; Bellot, P; Bhamidimarri, KR; Brainard, DM; Campos-Varela, I; Castells, L; Grewal, P; Guaraldi, G; Hasson, H; McHutchison, JG; Morbey, A; Moreno, A; Terrault, NA | 1 |
| Ferenci, P; Freissmuth, C; Graziadei, I; Gschwantler, M; Hametner, S; Hofer, H; Karpi, A; Kozbial, K; Laferl, H; Maieron, A; Moser, S; Ramona, AZ; Stauber, RE; Stern, R; Vogel, W; Zoller, HM | 1 |
| Mori, K; Noda, T; Ozaki, S; Sekimoto, E; Shibata, H; Shigekiyo, T; Shikiji, T; Sumitani, R; Yamashita, K | 1 |
| Bogomolov, P; Cooney, E; Critelli, L; Olveira, A; Pol, S; Reesink, HW; Santagostino, E; Srinivasan, S; van Erpecum, K; Xu, D | 1 |
| Abergel, A; Besch, C; Botta-Fridlund, D; Canva, V; Coilly, A; Conti, F; d'Alteroche, L; de Ledinghen, V; di Martino, V; Diallo, A; Duclos-Vallée, JC; Dumortier, J; Duvoux, C; Fougerou-Leurent, C; Francoz, C; Houssel-Debry, P; Kamar, N; Lebray, P; Leroy, V; Moreno, C; Pageaux, GP; Radenne, S; Rohel, A; Rossignol, E; Samuel, D; Tran, A | 1 |
| Flower, D; Heslop, R; Jordan, V; Roberts, H | 1 |
| Damrah, I; Eurich, D; Gül-Klein, S; Pratschke, J; Raschzok, N; Reutzel-Selke, A; Sauer, IM; Schott, E; Stockmann, M; Strücker, B | 1 |
| Ashimkhanova, A; Kaliaskarova, K; Yesmembetov, K | 1 |
| Bang, BR; Chopra, S; Cook, L; Elmasry, S; Feng, Z; Harper, T; Jerome, KR; Kahn, JA; Kanel, G; Kim, B; Saito, T; Wadhwa, S | 1 |
| Birkmann, A; Corey, L; Fife, K; Huang, ML; Johnston, C; Magaret, A; Ruebsamen-Schaeff, H; Selke, S; Stobernack, HP; Timmler, B; Tyring, S; Wald, A; Warren, T; Zimmermann, H | 1 |
| Berg, T; Ferenci, P; Herzer, K; Hinrichsen, H; Inderson, A; Jimenez-Exposito, MJ; Klinker, H; Peck-Radosavljevic, M; Spengler, U; Welzel, TM; Zeuzem, S; Zhao, Y | 1 |
| Almasio, PL; Bourgeois, S; Brown, A; Buggisch, P; DeMasi, R; Diago, M; Gaeta, GB; Hézode, C; Horsmans, Y; Lonjon-Domanec, I; Omoruyi, E; Planas, R; Schlag, M; Serfaty, L; Szalay, F; Zeuzem, S | 1 |
| Akremi, R; Bennai, Y; Botta-Fridlund, D; Bourliere, M; Boyer, N; Bronowicki, JP; D'Alteroche, L; De Ledinghen, V; Di Martino, V; Fedchuk, L; Filipovics, A; Fontaine, H; Guyader, D; Hézode, C; Hubert-Fouchard, I; Larrey, D; Lebray, P; Leroy, V; Nguyen-Khac, E; Rosa, I; Silvain, C; Zhao, Y; Zoulim, F | 1 |
| Castedal, M; Cederberg, S; Segenmark, M; Skoglund, C; Weiland, O | 1 |
| Bhasin, D; Pollinger, H; Rubin, RA; Shrestha, R; Stein, L; Tracy, B | 1 |
| Chiang, LY; Crawford, JR; Kuo, DJ | 1 |
| Andreone, P; Berenguer, M; Calleja, JL; Cieciura, T; Donato, MF; Durlik, M; Fagiuoli, S; Forns, X; Herzer, K; Janssen, K; Jessner, W; Kalmeijer, R; Lenz, O; Mariño, Z; Ouwerkerk-Mahadevan, S; Peeters, M; Shukla, U; Sterneck, M; Verbinnen, T | 1 |
| Brodell, RT; Cernik, C; Gallina, K | 1 |
| Corradi, L; Derosa, G; Ferrari, I; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A | 1 |
| Grond-Ginsbach, C; Kloss, M; Lichy, C; Wagner, C | 1 |
| Abudalu, M; Bodsworth, N; Hamed, K; Koltun, W; Tyring, S | 1 |
| Mateen, FJ; Mohr, DN | 1 |
| Patel, R | 1 |
| Munusamy, V; Nothnagle, M; Zaidi, N | 1 |
| Arnold, JM; Bourgoun, M; Califf, RM; Ghali, JK; Kober, L; McMurray, JJ; Meris, A; Pfeffer, MA; Skali, H; Solomon, SD; Velazquez, EJ; Verma, A | 1 |
| Barlera, S; Di Pasquale, G; Disertori, M; Franzosi, MG; Latini, R; Lucci, D; Maggioni, AP; Staszewsky, L; Tognoni, G | 1 |
| Hsiao, CH; Kao, LY; Lin, KK; Ma, DH; Tan, HY; Wang, NK; Yeh, LK; Yeung, L | 1 |
| Arslan, H; Bilezikçi, B; Haberal, M; Moray, G; Ozçay, F; Sevmiş, S | 1 |
| Ruiz-Villaverde, R; Sánchez-Cano, D | 1 |
| Lim, M; Lin, JP; Menson, E; Tong, CY | 1 |
| Al-Khatib, SM; Califf, RM; McMurray, JJ; Pfeffer, MA; Piccini, JP; Pieper, K; Solomon, SD; Van de Werf, F; Velazquez, EJ; Zhang, M | 1 |
| Brion, JP; Vitrat-Hincky, V | 1 |
| DesJardin, JA; Klein, A; Miller, KB; Snydman, DR; Sprague, K | 1 |
| Barlera, S; Cosmi, F; Di Pasquale, G; Disertori, M; Franzosi, MG; Latini, R; Lombardi, F; Maggioni, AP; Zeni, P | 1 |
| Dacey, M; Mehta, M; Stephen Foster, C | 1 |
| Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, J; Signorovitch, JE; Solomon, SD; Swedberg, K; Thune, JJ; Velazquez, E | 1 |
| French, LE; Hofbauer, GF; Nobbe, S; Trüeb, RM | 1 |
| Dal Cin, P; Hernandez, JM; Kuo, FC; Leon, A; Longtine, JA; Staropoli, JF | 1 |
| Chinuki, Y; Dekio, I; Furumura, M; Morita, E | 1 |
| Barlera, S; Bianconi, L; Disertori, M; Fabbri, G; Favero, C; Franzosi, MG; Latini, R; Lombardi, F; Lucci, D; Maggioni, AP; Quintarelli, S; Staszewsky, L | 1 |
| Hirose, S; Imafuku, S; Nakayama, J; Ohta, E; Yasumoto, S; Yoshimura, K | 1 |
| Corey, L; Huang, ML; Johnston, C; Koelle, DM; Kuntz, S; Magaret, A; Saracino, M; Schiffer, JT; Selke, S; Wald, A | 1 |
| Dimitrova, DI; Eley, T; Everson, GT; Gardiner, DF; Ghalib, R; Grasela, DM; Guo, T; Lawitz, E; Lok, AS; Martorell, C; McPhee, F; Pasquinelli, C; Persson, A; Reindollar, R; Rustgi, V; Wind-Rotolo, M; Zhu, K | 1 |
| Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA | 1 |
| Hashiguchi, H; Hashimoto, T; Kazuyama, Y; Kojima, Y; Shoji, H; Tsuji, S | 1 |
| Forster, GE; Kawsar, M; Khunda, A; Parkin, JM | 1 |
| Chosidow, O; Drouault, Y; Garraffo, R; Veyssier, P | 1 |
| Marina, RB; Roberts, JN; Romanowski, B | 1 |
| Grace, MG; Raborn, GW | 1 |
| Chan, KS; Grace, M; Raborn, GW | 1 |
| Hoehns, JD; Jensen, LA; Squires, CL | 1 |
| Ashley, R; Corey, L | 1 |
| Avdiushko, SA; Cunningham, LL; Lindroth, JE; Miller, CS | 1 |
| Färber, I | 1 |
| Avdiushko, SA; Danaher, RJ; Jacob, RJ; Kryscio, RJ; Miller, CS | 1 |
| Barge, RM; Beersma, MF; Bollemeijer, JG; Claas, EC; Kalpoe, JS; Kroes, AC; Vaessen, N; van Dehn, CE; Willemze, R | 1 |
| Anderson, BJ | 2 |
| Leone, P | 1 |
| Athanassiadou, P; Dardoufas, K; Gonidi, M; Kolitsi, G; Kouloulias, V; Kouvaris, J; Kyprianou, K; Nicolatou-Galitis, O; Papanikolaou, IS; Pissakas, G; Polychronopoulou, A; Skarleas, C; Sotiropoulou-Lontou, A | 1 |
| Califf, R; Howlett, J; Køber, L; Maggioni, A; McMurray, J; Pfeffer, M; Pieper, K; Reed, S; Rouleau, J; Solomon, S; Swedberg, K; Van de Werf, F; Velazquez, E; White, H | 1 |
| Andrews, WW; Cliver, S; Deeter, R; Kimberlin, DF; Ramsey, PS; Whitley, R | 1 |
| Aoki, FY; Corey, L; Diaz-Mitoma, F; Sacks, S; Selke, S; Wald, A; Warren, T | 1 |
| Delise, P; Di Pasquale, G; Disertori, M; Franzosi, MG; Latini, R; Maggioni, AP; Staszewsky, L; Tognoni, G | 1 |
| Brantley, JS; Hicks, L; Sra, K; Tyring, SK | 1 |
| Egashira, K; Funakoshi, K; Ihara, Y; Nakano, K; Ohtani, K; Sata, M; Sunagawa, K; Zhao, G | 1 |
| Almekinder, J; Fife, KH; Ofner, S | 1 |
| Shalabi, M; Whitley, RJ | 1 |
| Burroughs, SM; Ferrera, RD; Fife, KH; Heitman, CK; Justus, SE; Warren, TJ; Young, DG | 1 |
| Handsfield, HH; Phillips, JA; Warren, T; Werner, M | 1 |
| Au, WY; Fung, A; Kwong, YL; Lam, CC; Lam, KY; Lie, AK | 1 |
| Caughey, AB; Lurie, P; Urato, AC | 1 |
| Bouzamondo, A; Chosidow, O; Dupuy, A; Guillaume, JC; Lebrun-Vignes, B; Lechat, P | 1 |
| Alfonsi, N; Baudouin, C; Doan, S; Gabison, EE; Hoang-Xuan, T; Racine, L; Sultan, G | 1 |
| Beelen, DW; Ditschkowski, M; Elmaagacli, AH; Koldehoff, M; Steckel, NK | 1 |
| Gilbert, SC | 1 |
| Ogawa, H; Sakamoto, T; Shintomi, Y; Yoshimura, M | 1 |
| Bedane, C; Bonnetblanc, JM; Bordessoule, D; Cendras, J; Soria, P; Sparsa, A; Turlure, P | 1 |
| Agut, H; Binetruy, C; Bossi, P; Bricaire, F; Deback, C; Roubaud-Baudron, C | 1 |
| Steensma, DP; Tefferi, A | 1 |
| Almekinder, J; Bavaro, JB; Drolette, L; Koelle, DM; Tyring, S; Wald, A; Warren, T | 1 |
| Shimomura, Y | 1 |
| Fife, KH; Heitman, CK; Justus, SE; Warren, TJ | 1 |
| Cowen, PJ; McTavish, SF; Park, SB; Williamson, DJ | 1 |
| Faulds, D; Perry, CM | 1 |
| Wald, A | 1 |
| Bodsworth, NJ; Gibb, A; Patel, R; Peters, B; Robinson, J; Saari, S; Vejlsgaard, G; Woolley, P | 1 |
| Bodsworth, NJ; Borelli, S; Crooks, RJ; Esmann, J; Gibb, A; Ingamells, AJ; Paavonen, J; Strand, A; Uexkull, N; Vejlsgaard, G; Worm, AM | 1 |
| Corey, L; Douglas, JM; Esmann, J; Spruance, SL; Tyring, SK | 1 |
| Assier-Bonnet, H; Blanc, F; Esnault-Gelly, P; Kerob, D; Saiag, P | 1 |
| Borelli, S; Chambers, LO; Corey, L; Lang, W; Reitano, M; Robinson, JM; Thoming, C; Tyring, S; Worm, AM | 1 |
| Angel, S; Boineau-Géniaux, D; Chosidow, O; Grognard, C; Perrot, JL; Salag, P; Trepsat, F; Will, F | 1 |
| Andrews, WW; Hauth, JC; Kimberlin, DF; Lakeman, F; Miller, G; Weller, S; Whitley, RJ | 1 |
| Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C | 1 |
| Baker, DA; Blythe, JG; Miller, JM | 1 |
| Hara, K; Horigome, T; Kobayashi, T; Sugita, N; Van De Winkel, JG; Van Der Pol, W; Yamamoto, K; Yoshie, H | 1 |
| Chastang, C; Praindhui, D; Saiag, P | 1 |
| Field, HJ; Thackray, AM | 2 |
| Sarrecchia, C; Testore, GP; Volpi, A | 1 |
| Gilbert, S; McBurney, E | 1 |
| Grant, DM; Patel, R; Price, MJ; Strand, A; Tyring, S | 1 |
| Azoulay, E; Coudrec, LJ; Massiani, MA; Rivaud, E; Vincent, F | 1 |
| Brodell, RT; Guerriere-Kovach, PM | 1 |
| Geers, TA; Isada, CM | 1 |
| Brown, D; Drake, S; Pillay, D; Taylor, S | 1 |
| Ellis, SG | 1 |
| Brattström, A; Götting, B; Peters, S; Rust, H; Trümmel, M | 1 |
| Asensio Sánchez, VM | 1 |
| Bernasconi, E; Gobbi, C; Merenda, C; Städler, C; Tosi, C | 1 |
| Aoki, FY; Bras, AP; Sitar, DS | 1 |
| Conant, MA; Crooks, RJ; Crutchfield, LT; Gold, J; Murphy, RL; Schacker, TW | 1 |
| Beeson, WH; Rachel, JD | 1 |
| Rosenthal, SL; Stanberry, LR | 1 |
| Abraham, G; Carter, C; Cooper, DN; Kakkar, VV; White, D | 1 |
21 review(s) available for valine and Recrudescence
| Article | Year |
|---|---|
Recurrent Meningitis.
Topics: Acyclovir; Antibodies, Monoclonal; Antiviral Agents; Diagnosis, Differential; Herpes Simplex; Herpesvirus 2, Human; Humans; Meningitis; Meningitis, Aseptic; Prognosis; Recurrence; Secondary Prevention; Valacyclovir; Valine | 2017 |
Management of Recurrent Vestibular Neuritis in a Patient Treated for Rheumatoid Arthritis.
Topics: Acyclovir; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Middle Aged; Prognosis; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Valacyclovir; Valine; Vertigo; Vestibular Function Tests; Vestibular Neuronitis | 2018 |
[Acute herpes simplex virus type 1 retinal necrosis three years after herpes simplex encephalitis].
Topics: Acyclovir; Antiviral Agents; Aspirin; Cataract Extraction; Causality; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Methylprednisolone; Middle Aged; Recurrence; Retinal Detachment; Retinal Hemorrhage; Retinal Necrosis Syndrome, Acute; Time Factors; Valacyclovir; Valine; Vitrectomy | 2014 |
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Adult; Antiviral Agents; Famciclovir; Female; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Immunocompetence; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Valacyclovir; Valine | 2014 |
Hepatitis C management in post-transplant patients.
Topics: Antiviral Agents; Benzimidazoles; Carbamates; Drug Therapy, Combination; Fluorenes; Hepatitis C; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Oligopeptides; Polyethylene Glycols; Proline; Pyrrolidines; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; Simeprevir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uridine Monophosphate; Valine; Viral Load | 2015 |
Management of post transplant hepatitis C in the direct antiviral agents era.
Topics: Antiviral Agents; Carbamates; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Liver Transplantation; Oligopeptides; Postoperative Complications; Proline; Protease Inhibitors; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Valine; Viral Nonstructural Proteins | 2015 |
Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis.
Topics: 2-Aminopurine; Acyclovir; Administration, Cutaneous; Administration, Oral; Adrenal Cortex Hormones; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Female; Herpes Labialis; Humans; Recurrence; Treatment Outcome; Valacyclovir; Valine | 2015 |
Diffuse large B-cell lymphoma recurring with zosteriform cutaneous lesions.
Topics: Acyclovir; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Herpes Zoster; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Recurrence; Rituximab; Skin Neoplasms; Treatment Outcome; Valacyclovir; Valine; Vincristine | 2016 |
Interventions for men and women with their first episode of genital herpes.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Female; Herpes Genitalis; Humans; Injections, Intravenous; Male; Randomized Controlled Trials as Topic; Recurrence; Valacyclovir; Valine | 2016 |
The treatment of herpes simplex infections: an evidence-based review.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Drug Resistance, Viral; Evidence-Based Medicine; Famciclovir; Herpes Genitalis; Herpes Labialis; Humans; Recurrence; Risk Factors; Valacyclovir; Valine | 2008 |
[Herpesvirus infections of the immunocompetant child and adult].
Topics: Acetaminophen; Acyclovir; Administration, Oral; Adult; Aged; Analgesics, Non-Narcotic; Antiviral Agents; Chickenpox; Child, Preschool; Female; Herpes Simplex; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Immunocompetence; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Recurrence; Seroepidemiologic Studies; Valacyclovir; Valine | 2009 |
Recurrent herpes simplex labialis: selected therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Adult; Antiviral Agents; Child; Drug Combinations; Famciclovir; Herpes Labialis; Herpesvirus 1, Human; Humans; Recurrence; Valacyclovir; Valine | 2003 |
Oral antivirals for the acute treatment of recurrent herpes labialis.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Herpes Labialis; Humans; Recurrence; Valacyclovir; Valine | 2004 |
Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
Topics: Acyclovir; Antiviral Agents; Clinical Trials as Topic; Herpes Genitalis; Humans; Recurrence; Sexual Behavior; Valacyclovir; Valine; Virus Shedding | 2004 |
Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Topics: Acyclovir; Coitus; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Recurrence; United States; Valacyclovir; Valine | 2005 |
Valacyclovir for the treatment of genital herpes.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Herpes Genitalis; Herpes Zoster; Humans; Recurrence; Valacyclovir; Valine | 2006 |
A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Antiviral Agents; Disease Outbreaks; Drug Administration Schedule; Famciclovir; Herpes Genitalis; Humans; Randomized Controlled Trials as Topic; Recurrence; Risk; Treatment Outcome; Valacyclovir; Valine | 2007 |
[Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Topics: Acyclovir; Animals; Antiviral Agents; Biomarkers; Chemokines; DNA, Viral; Dosage Forms; Humans; Keratitis, Herpetic; Recurrence; Simplexvirus; Surveys and Questionnaires; Valacyclovir; Valine; Virus Latency | 2008 |
Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Topics: Acyclovir; Adult; Animals; Antiviral Agents; Drug Resistance, Microbial; Drug Tolerance; Herpes Genitalis; Herpes Zoster; Herpesviridae; Herpesviridae Infections; Humans; Middle Aged; Recurrence; Valacyclovir; Valine | 1996 |
Improving the care of patients with genital herpes.
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Cesarean Section; Drug Administration Schedule; Famciclovir; Female; Herpes Genitalis; Humans; Immunocompromised Host; Infant, Newborn; Male; Patient Education as Topic; Pemphigoid Gestationis; Pregnancy; Prevalence; Quality Assurance, Health Care; Recurrence; Valacyclovir; Valine | 2000 |
Genital herpes simplex virus infection in the adolescent: special considerations for management.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Antiviral Agents; Complementary Therapies; Famciclovir; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Recurrence; Valacyclovir; Valine | 2002 |
53 trial(s) available for valine and Recrudescence
| Article | Year |
|---|---|
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Double-Blind Method; Electrocardiography; Female; Fibrinolytic Agents; Guideline Adherence; Hemorrhage; Humans; Incidence; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Practice Guidelines as Topic; Practice Patterns, Physicians'; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Telemetry; Tetrazoles; Thromboembolism; Time Factors; Treatment Outcome; Valine; Valsartan; Warfarin | 2013 |
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
Topics: Acyclovir; Adolescent; Adult; Aged; Cytokines; Double-Blind Method; Female; Gels; Herpes Simplex; Humans; Imidazoles; Male; Middle Aged; Recurrence; Simplexvirus; Valacyclovir; Valine; Wound Healing; Young Adult | 2014 |
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Death, Sudden, Cardiac; Drug Therapy, Combination; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Myocardial Infarction; Quality of Life; Recurrence; Stroke; Survivors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.
Topics: Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Logistic Models; Macrocyclic Compounds; Male; Middle Aged; Proline; Recurrence; Ribavirin; Sulfonamides; Valine | 2014 |
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
Topics: Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Recurrence; Ribavirin; RNA, Viral; Sulfonamides; Valine | 2014 |
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrrolidines; Recurrence; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Uridine Monophosphate; Valine | 2014 |
Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.
Topics: Administration, Oral; Aged; Anilides; Antiviral Agents; Carbamates; Carrier Proteins; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Intracellular Signaling Peptides and Proteins; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Proline; Recurrence; Remission Induction; Ritonavir; Sulfonamides; Time Factors; Treatment Outcome; United States; Valine; Viral Nonstructural Proteins | 2015 |
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir; Valine | 2016 |
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
Topics: Adult; Antiviral Agents; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferon-alpha; Interferons; Interleukins; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Valine; Young Adult | 2016 |
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.
Topics: Aged; Antiviral Agents; Belgium; Carbamates; Compassionate Use Trials; Female; France; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pyrrolidines; Recurrence; Reoperation; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2016 |
The impact of directly acting antivirals on the enzymatic liver function of liver transplant recipients with recurrent hepatitis C.
Topics: Administration, Oral; Aged; Antiviral Agents; Biopsy; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Liver; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Tacrolimus; Transaminases; Valine | 2016 |
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cross-Over Studies; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Middle Aged; Pyridines; Recurrence; Sulfonamides; Thiazoles; Valacyclovir; Valine; Virus Shedding; Young Adult | 2016 |
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrrolidines; Recurrence; RNA, Viral; Simeprevir; Sustained Virologic Response; Valine; Young Adult | 2017 |
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Simeprevir; Tacrolimus; Treatment Outcome; Valine; Viral Load | 2017 |
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Humans; Male; Peptide Fragments; Procollagen; Ramipril; Recurrence; Tetrazoles; Valine; Valsartan | 2008 |
Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Famciclovir; Female; Herpes Genitalis; Humans; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome; Valacyclovir; Valine; Young Adult | 2008 |
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Europe; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; United States; Valine; Valsartan; Ventricular Remodeling | 2008 |
Valsartan for prevention of recurrent atrial fibrillation.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Cardiomegaly; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Double-Blind Method; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Tetrazoles; Valine; Valsartan | 2009 |
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2010 |
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Double-Blind Method; Female; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Male; Middle Aged; Recurrence; Time Factors; Valacyclovir; Valine | 2011 |
Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Diuretics; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Recurrence; Risk Factors; Tetrazoles; Valine; Valsartan | 2010 |
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
Topics: Age Factors; Aged; Captopril; Cause of Death; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Sex Factors; Survival Analysis; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2011 |
Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Incidence; Italy; Male; Prognosis; Prospective Studies; Recurrence; Tetrazoles; Valine; Valsartan | 2011 |
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Cross-Over Studies; DNA, Viral; Drug Administration Schedule; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Valacyclovir; Valine | 2012 |
Preliminary study of two antiviral agents for hepatitis C genotype 1.
Topics: Adult; Antiviral Agents; Carbamates; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Valine | 2012 |
Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial.
Topics: Acyclovir; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Herpes Labialis; Humans; Male; Middle Aged; Pilot Projects; Prodrugs; Recurrence; Treatment Outcome; Valacyclovir; Valine | 2003 |
Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.
Topics: Acyclovir; Administration, Oral; Adult; Aged; Aged, 80 and over; Antiviral Agents; Canada; Cross-Over Studies; Drug Administration Schedule; Female; Herpes Genitalis; Humans; Male; Middle Aged; Patient Satisfaction; Quality of Life; Recurrence; Treatment Outcome; Valacyclovir; Valine | 2003 |
The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Child; Dental Care; Double-Blind Method; Female; Follow-Up Studies; Herpes Labialis; Humans; Male; Middle Aged; Placebos; Premedication; Prodrugs; Prospective Studies; Recurrence; Saliva; Simplexvirus; Stomatitis, Herpetic; Treatment Outcome; Valacyclovir; Valine; Virus Shedding | 2004 |
Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Child; Dental Care; DNA, Viral; Female; Herpes Simplex; Humans; Male; Middle Aged; Recurrence; Saliva; Simplexvirus; Valacyclovir; Valine; Virus Shedding | 2005 |
Valacyclovir to expedite the clearance of recurrent herpes gladiatorum.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Valacyclovir; Valine; Wrestling | 2005 |
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
Topics: Acyclovir; Adult; Antiviral Agents; Double-Blind Method; Female; Herpes Genitalis; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Valacyclovir; Valine | 2006 |
Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Famciclovir; Female; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Male; Patient Compliance; Recurrence; Valacyclovir; Valine; Virus Shedding | 2006 |
Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Double-Blind Method; Echocardiography; Humans; Italy; Prospective Studies; Recurrence; Research Design; Tetrazoles; Valine; Valsartan | 2006 |
A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
Topics: Acyclovir; Adult; Antiviral Agents; Disease-Free Survival; Drug Administration Schedule; Female; Herpes Genitalis; Humans; Male; Middle Aged; North Carolina; Recurrence; Severity of Illness Index; Treatment Outcome; Valacyclovir; Valine | 2007 |
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Topics: Acyclovir; Adult; Antiviral Agents; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Middle Aged; Patient Compliance; Prodrugs; Recurrence; Treatment Outcome; United States; Valacyclovir; Valine; Virus Shedding | 2006 |
Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Topics: Acyclovir; Adolescent; Adult; Ambulatory Care Facilities; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Female; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Male; Oregon; Pilot Projects; Quality of Life; Recurrence; Treatment Outcome; Valacyclovir; Valine; Washington | 2007 |
Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cross-Over Studies; Drug Administration Schedule; Female; Headache; Herpes Labialis; Humans; Lip Diseases; Male; Middle Aged; Recurrence; Sinusitis; Time Factors; Treatment Outcome; Valacyclovir; Valine | 2007 |
An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Brazil; Canada; Chile; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; United States; Valacyclovir; Valine | 2008 |
Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
Topics: Adult; Affect; Aged; Amino Acids, Branched-Chain; Amitriptyline; Antidepressive Agents; Blood-Brain Barrier; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fenfluramine; Humans; Lithium; Male; Middle Aged; Personality Inventory; Prolactin; Recurrence; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan; Valine | 1995 |
Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Female; Follow-Up Studies; Herpes Genitalis; Humans; Male; Middle Aged; Proportional Hazards Models; Recurrence; Valacyclovir; Valine | 1997 |
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Disease Progression; Double-Blind Method; Female; Herpes Genitalis; Humans; Male; Middle Aged; Pain Measurement; Proportional Hazards Models; Recurrence; Self Medication; Time Factors; Valacyclovir; Valine; Virus Shedding; Wound Healing | 1997 |
A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Confidence Intervals; Double-Blind Method; Female; Herpes Genitalis; Humans; Immunocompetence; Male; Middle Aged; Pain; Placebos; Prodrugs; Proportional Hazards Models; Recurrence; Remission Induction; Self Care; Time Factors; Valacyclovir; Valine; Virus Shedding; Wound Healing | 1998 |
Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Herpes Simplex; Humans; Male; Recurrence; Simplexvirus; Treatment Outcome; Valacyclovir; Valine | 1998 |
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
Topics: Acyclovir; Adult; Antiviral Agents; Double-Blind Method; Female; Gestational Age; Herpes Genitalis; Herpesvirus 2, Human; Humans; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Recurrence; Valacyclovir; Valine | 1998 |
Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes.
Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Administration Schedule; Female; Follow-Up Studies; Herpes Genitalis; Humans; Male; Middle Aged; Recurrence; Valacyclovir; Valine | 1999 |
The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Minnesota; Recurrence; Sampling Studies; Treatment Outcome; Valacyclovir; Valine; Wrestling | 1999 |
A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes. Genival Study Group.
Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Female; Herpes Genitalis; Humans; Male; Middle Aged; Recurrence; Valacyclovir; Valine | 1999 |
Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: A randomized clinical trial of dosing regimens.
Topics: Acyclovir; Antiviral Agents; Chemexfoliation; Dermabrasion; Drug Administration Schedule; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Laser Therapy; Male; Middle Aged; Postoperative Complications; Premedication; Recurrence; Rhytidoplasty; Valacyclovir; Valine; Virus Activation | 2000 |
Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection.
Topics: Acyclovir; Adult; Analysis of Variance; Antiviral Agents; Dose-Response Relationship, Drug; Double-Blind Method; Herpes Genitalis; Humans; Quality of Life; Recurrence; Retrospective Studies; Surveys and Questionnaires; Valacyclovir; Valine | 1999 |
Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagonists; Antihypertensive Agents; Coronary Disease; Female; Humans; Male; Middle Aged; Recurrence; Stents; Tetrazoles; Valine; Valsartan | 2001 |
Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
Topics: Acyclovir; Administration, Oral; Adult; Analysis of Variance; Antiviral Agents; Area Under Curve; Biological Availability; Double-Blind Method; Female; Herpes Genitalis; Humans; Male; Middle Aged; Recurrence; Valacyclovir; Valine | 2001 |
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
Topics: Acyclovir; Adult; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Recurrence; Simplexvirus; Treatment Outcome; Valacyclovir; Valine | 2002 |
Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Dermatologic Surgical Procedures; Face; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Laser Therapy; Male; Middle Aged; Prodrugs; Prospective Studies; Recurrence; Valacyclovir; Valine; Virus Activation | 2002 |
93 other study(ies) available for valine and Recrudescence
| Article | Year |
|---|---|
The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
Topics: Animals; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Granulocyte Colony-Stimulating Factor; Inflammation Mediators; Interleukin-6; Mice; Raffinose; Recurrence; Treatment Outcome; Tryptophan; Tumor Necrosis Factor-alpha; Valine; Vancomycin | 2022 |
Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.
Topics: Aged; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Fatal Outcome; Hepacivirus; Hepatitis C; Humans; Imidazoles; Isoquinolines; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pyrrolidines; Radiofrequency Ablation; Recurrence; Sulfonamides; Valine; Viral Load | 2020 |
A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir.
Topics: Antiviral Agents; Brazil; Carbamates; Cell Line, Tumor; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Mutation; Pyrrolidines; Recurrence; Sofosbuvir; Valine; Viral Nonstructural Proteins; Virus Replication | 2021 |
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
Topics: Antiviral Agents; Carbamates; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2017 |
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Female; Hepatitis C; Humans; Imidazoles; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrrolidines; Recurrence; Retrospective Studies; Spain; Sustained Virologic Response; Valine | 2017 |
Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience.
Topics: Adult; Aged; Carbamates; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Imidazoles; Isoquinolines; Japan; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Protease Inhibitors; Pyrrolidines; Recurrence; Risk Factors; Sulfonamides; Valine | 2017 |
Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Infant; Keratitis, Herpetic; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Recurrence; Tears; Valacyclovir; Valine; Young Adult | 2017 |
A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population.
Topics: Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Phenotype; Pyrrolidines; Recurrence; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Time Factors; Treatment Outcome; Valine; Viral Load | 2018 |
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Imidazoles; Italy; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Valine | 2018 |
Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation.
Topics: Aged; Antiviral Agents; Austria; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2018 |
Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
Topics: Aged; Amino Acid Sequence; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Isoquinolines; Liver Cirrhosis; Phylogeny; Polymerase Chain Reaction; Pyrrolidines; Recurrence; RNA, Viral; Sequence Homology, Amino Acid; Sulfonamides; Sustained Virologic Response; Valine | 2018 |
HCV genotype-3h, a difficult-to-diagnose sub-genotype in the DAA era.
Topics: 2-Naphthylamine; Aged; Amino Acid Substitution; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Isoenzymes; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Polymorphism, Genetic; Proline; Recurrence; Ribavirin; Sulfonamides; Treatment Failure; Uracil; Valine; Viral Load; Viral Nonstructural Proteins | 2018 |
Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling.
Topics: Aged; Anilides; Antiviral Agents; Carbamates; Hepatitis C, Chronic; Humans; Male; Models, Molecular; Molecular Dynamics Simulation; Mutation, Missense; Polymorphism, Genetic; Proline; Recurrence; Treatment Failure; Valine; Viral Nonstructural Proteins | 2018 |
Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study.
Topics: Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2018 |
Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Incidence; Isoquinolines; Male; Middle Aged; Pyrrolidines; Recurrence; RNA, Viral; Sulfonamides; Sustained Virologic Response; Valine; Young Adult | 2018 |
Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Italy; Liver Cirrhosis; Polymorphism, Genetic; Prospective Studies; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Sustained Virologic Response; Valine | 2018 |
Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation.
Topics: Aged; Antiviral Agents; Carbamates; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Isoquinolines; Liver Transplantation; Living Donors; Male; Middle Aged; Prospective Studies; Pyrrolidines; Recurrence; Sulfonamides; Tacrolimus; Time Factors; Treatment Outcome; Valine; Viral Load | 2018 |
Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunocompromised Host; Isoquinolines; Liver Transplantation; Living Donors; Middle Aged; Pyrrolidines; Recurrence; Sulfonamides; Valine | 2018 |
Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Male; Middle Aged; Pyrrolidines; Recurrence; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2019 |
A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens.
Topics: Antiviral Agents; Carbamates; Cell Death; Cell Line, Tumor; Drug Synergism; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Intracellular Space; Pyrrolidines; Recurrence; Simeprevir; Sofosbuvir; Valine; Virus Replication | 2019 |
Recurrent hepatitis C treatment with direct acting antivirals - a real life study at a Brazilian liver transplant center.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepatitis C; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Retrospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine; Viral Load | 2019 |
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.
Topics: Carbamates; Cholestasis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; RNA, Viral; Sofosbuvir; Transplantation, Homologous; Uridine Monophosphate; Valine | 2013 |
Herpes simplex virus lymphadenitis.
Topics: Acyclovir; Antibodies, Viral; Biopsy; Herpesviridae Infections; Humans; Immunoglobulin G; Immunohistochemistry; Immunosuppression Therapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphadenitis; Male; Middle Aged; Recurrence; Simplexvirus; Valacyclovir; Valine | 2014 |
Recurrent palmar blister.
Topics: Acyclovir; Adult; Antiviral Agents; Blister; Diagnosis, Differential; Female; Hand Dermatoses; Herpes Simplex; Humans; Prodrugs; Real-Time Polymerase Chain Reaction; Recurrence; Valacyclovir; Valine | 2014 |
[Normokalemic periodic paralysis lasting for two weeks: a severe form of sodium channelopathy with M1592V mutation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Channelopathies; Eyelid Diseases; Female; Heterozygote; Humans; Male; Methionine; Middle Aged; Mutation; Myotonia; NAV1.4 Voltage-Gated Sodium Channel; Paralyses, Familial Periodic; Pedigree; Recurrence; Sodium Channels; Time Factors; Valine; Young Adult | 2014 |
Low relapse rate leads to high concordance of sustained virologic response (SVR) at 12 weeks with SVR at 24 weeks after treatment with ABT-450/ritonavir, ombitasvir, and dasabuvir plus ribavirin in subjects with chronic hepatitis C virus genotype 1 infect
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Proline; Recurrence; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Uracil; Valine; Viral Load | 2015 |
Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.
Topics: Acyclovir; Antiviral Agents; Costs and Cost Analysis; Herpes Genitalis; Humans; Male; Medical Audit; Recurrence; Simplexvirus; Treatment Outcome; Valacyclovir; Valine; Virus Shedding | 2015 |
Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant.
Topics: Antiviral Agents; Carbamates; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Valine; Viral Load; Viremia | 2015 |
Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplant.
Topics: Antiviral Agents; Biomarkers; Carbamates; Drug Therapy, Combination; End Stage Liver Disease; Hepatitis B virus; Hepatitis C; Humans; Imidazoles; Liver Transplantation; Male; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir; Time Factors; Treatment Outcome; Valine; Viral Load; Virus Activation | 2015 |
Herpes zoster: a potential risk associated with fingolimod treatment.
Topics: Acyclovir; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fingolimod Hydrochloride; Follow-Up Studies; Herpes Zoster; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis; Recurrence; Risk Assessment; Treatment Outcome; Valacyclovir; Valine | 2015 |
The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.
Topics: Adult; Amino Acid Substitution; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Gene Frequency; Glutamic Acid; Humans; Male; Middle Aged; Mutation, Missense; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins B-raf; Recurrence; Risk Factors; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2015 |
Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.
Topics: Adult; Aged; Carbamates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Isoquinolines; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrrolidines; Recurrence; Sampling Studies; Sulfonamides; Tacrolimus; Valine | 2016 |
Erythema Multiforme.
Topics: Acyclovir; Adult; Anesthetics, Local; Antiviral Agents; Diagnosis, Differential; Drug Therapy, Combination; Erythema Multiforme; Female; Glucocorticoids; Humans; Lidocaine; Methylprednisolone; Recurrence; Valacyclovir; Valine | 2015 |
Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Genotype; Graft Survival; Hepacivirus; Hepatitis C; HIV Infections; Humans; Immunosuppressive Agents; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Recurrence; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome; Uracil; Valine | 2016 |
Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cost-Benefit Analysis; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Markov Chains; Middle Aged; Models, Economic; Phenotype; Proline; Recurrence; Ribavirin; Risk Factors; Ritonavir; Sulfonamides; Time Factors; Treatment Outcome; United States; Uracil; Valine; Viral Load; Virus Activation | 2016 |
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Topics: Aged; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Valine | 2016 |
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Transplant Recipients; Treatment Outcome; Valine | 2016 |
Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Carbamates; Drug Therapy, Combination; Fatigue; Female; Fluorenes; Hepatitis C, Chronic; Humans; Imidazoles; Male; Pruritus; Pyrrolidines; Recurrence; Simeprevir; Sleep Initiation and Maintenance Disorders; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2016 |
First Case in Kazakhstan of Successful Therapy With 2 Consecutive Direct-Acting Antiviral Regimens in a Patient with Hepatitis C Virus-Induced Decompensated Liver Cirrhosis on a Liver Transplant Wait List.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Hepatitis C; Humans; Kazakhstan; Lactams, Macrocyclic; Liver Cirrhosis; Liver Transplantation; Macrocyclic Compounds; Male; Medication Adherence; Proline; Recurrence; Retreatment; Ritonavir; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Time Factors; Treatment Outcome; Uracil; Valine; Waiting Lists | 2016 |
Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Benzimidazoles; Carbamates; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Limit of Detection; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrrolidines; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine; Viral Load; Virus Replication | 2017 |
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Cohort Studies; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2017 |
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; France; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Sustained Virologic Response; Valine | 2017 |
INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Sweden; Treatment Outcome; Valine | 2017 |
Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure.
Topics: Acute Disease; Administration, Oral; Antiviral Agents; Carbamates; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Risk Factors; Sofosbuvir; Valine | 2017 |
Unilateral facial nerve palsy as an early presenting symptom of relapse in a paediatric patient with acute lymphoblastic leukaemia.
Topics: Acyclovir; Adolescent; Antiviral Agents; Bell Palsy; Central Nervous System Neoplasms; Facial Nerve; Humans; Magnetic Resonance Imaging; Male; Optic Nerve Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recovery of Function; Recurrence; Spinal Puncture; Treatment Outcome; Valacyclovir; Valine | 2017 |
A glycine-valine substitution in alpha2 type V procollagen associated with recurrent cervical artery dissection.
Topics: Adult; Amino Acid Substitution; Carotid Artery, Internal, Dissection; Collagen Type V; Glycine; Humans; Male; Mutation, Missense; Recurrence; Valine | 2008 |
45-year-old woman with recurrent headache and photophobia.
Topics: Acyclovir; Anti-Bacterial Agents; Antiviral Agents; Aspirin; Diagnosis, Differential; Female; Headache; Humans; Meningitis, Viral; Middle Aged; Photophobia; Recurrence; Spinal Puncture; Valacyclovir; Valine | 2008 |
Making the most of episodic antiviral therapy for genital herpes.
Topics: Acyclovir; Antiviral Agents; Drug Administration Schedule; Herpes Genitalis; Humans; Recurrence; Treatment Outcome; Valacyclovir; Valine; Virus Shedding | 2008 |
Recurring meningitis: recurrence after suppressive therapy--can we call for life-long prophylaxis?
Topics: Acyclovir; Adult; Antiviral Agents; Female; Humans; Meningitis, Viral; Recurrence; Simplexvirus; Valacyclovir; Valine | 2008 |
Pediatric herpes simplex virus keratitis.
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Female; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Infant; Keratitis, Herpetic; Male; Recurrence; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Valacyclovir; Valine; Virus Cultivation; Visual Acuity | 2009 |
The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Body Weight; Child, Preschool; Chronic Disease; Epstein-Barr Virus Infections; Humans; Infant; Liver Function Tests; Liver Transplantation; Postoperative Complications; Recurrence; Retrospective Studies; Valacyclovir; Valine; Viral Load; Virus Activation | 2009 |
[Chronic suppressive therapy in recurrent herpes labia with valacyclovir in adolescents. Our experience].
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Female; Herpes Labialis; Humans; Male; Recurrence; Valacyclovir; Valine | 2009 |
Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children.
Topics: Acyclovir; Antiviral Agents; Cerebrospinal Fluid; Drug Monitoring; Encephalitis, Viral; Herpes Simplex; Humans; Infant; Plasma; Recurrence; Simplexvirus; Valacyclovir; Valine | 2009 |
Recurrent conjunctivitis and scleritis secondary to coexistent conjunctival pemiphigus vulgaris and cryptic herpes simplex infection: a case report.
Topics: Acyclovir; Antiviral Agents; Conjunctival Diseases; Conjunctivitis; Female; Herpes Simplex; Humans; Immunoglobulins, Intravenous; Medical Records; Middle Aged; Necrosis; Pemphigus; Recurrence; Retrospective Studies; Scleritis; Valacyclovir; Valine | 2010 |
Herpes simplex virus reactivation as a complication of photodynamic therapy.
Topics: Acyclovir; Aged, 80 and over; Antibiotic Prophylaxis; Antiviral Agents; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Photochemotherapy; Recurrence; Valacyclovir; Valine | 2011 |
Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 9; Cohort Studies; Disease Progression; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Recurrence; Thrombocythemia, Essential; Translocation, Genetic; Valine | 2011 |
Recurrent Kaposi's varicelliform eruption successfully controlled by low-dose oral valaciclovir.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Dermatitis, Atopic; Humans; Immunoglobulin G; Kaposi Varicelliform Eruption; Male; Ointments; Recurrence; Treatment Outcome; Valacyclovir; Valine; Vidarabine; Young Adult | 2012 |
Persistent cutaneous neonatal herpes caused by Herpes simplex virus-2.
Topics: Acyclovir; Antiviral Agents; Herpes Simplex; Herpesvirus 2, Human; Humans; Infant, Newborn; Male; Recurrence; Skin Diseases, Viral; Valacyclovir; Valine | 2012 |
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Reoperation; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Valine; Viral Load | 2012 |
Recurrent herpes simplex virus type 2 meningitis: a case report of Mollaret's meningitis.
Topics: Acyclovir; Adult; Antiviral Agents; Herpes Genitalis; Herpesvirus 2, Human; Humans; Japan; Male; Meningitis, Viral; Polymerase Chain Reaction; Recurrence; Time Factors; Valacyclovir; Valine | 2002 |
Successful use of valciclovir in a case of recurrent urticaria associated with genital herpes.
Topics: Acyclovir; Adult; Antiviral Agents; Female; Herpes Genitalis; Humans; Recurrence; Urticaria; Valacyclovir; Valine | 2002 |
Treatment modalities and medication recommended by health care professionals for treating recurrent herpes labialis.
Topics: 2-Aminopurine; Acyclovir; Alberta; Antiviral Agents; Attitude of Health Personnel; Dentists; Drug Costs; Famciclovir; Female; Herpes Labialis; Humans; Male; Nonprescription Drugs; Pharmacists; Physicians, Family; Prodrugs; Recurrence; Stress, Psychological; Valacyclovir; Valine | 2004 |
[How contagious is herpes?].
Topics: Acyclovir; Antiviral Agents; Herpes Labialis; Humans; Recurrence; Valacyclovir; Valine | 2005 |
Varicella zoster virus (VZV)-related progressive outer retinal necrosis (PORN) after allogeneic stem cell transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; DNA, Viral; Eye Infections, Viral; Herpesvirus 3, Human; Humans; Laser Coagulation; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retinal Necrosis Syndrome, Acute; Stem Cell Transplantation; Transplantation, Homologous; Valacyclovir; Valine | 2005 |
Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis.
Topics: Abnormalities, Radiation-Induced; Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; Candidiasis, Oral; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Herpes Simplex; Herpesvirus 1, Human; Humans; Incidence; Male; Middle Aged; Oral Ulcer; Radiotherapy; Recurrence; Stomatitis; Treatment Outcome; Valacyclovir; Valine | 2006 |
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Captopril; Cardiovascular Diseases; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Valine; Valsartan | 2006 |
Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Biomarkers; Blood Pressure; Blood Vessels; Cell Differentiation; Constriction, Pathologic; Iliac Artery; Imidazoles; Inflammation; Inflammation Mediators; Isoenzymes; Macaca fascicularis; Male; Monocytes; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Rabbits; Recurrence; Renin-Angiotensin System; Stem Cells; Stents; Tetrazoles; Tunica Intima; Valine; Valsartan | 2006 |
Recurrent benign lymphocytic meningitis.
Topics: 2-Aminopurine; Acyclovir; Adult; Aged; Antiviral Agents; Famciclovir; Female; Herpesvirus 2, Human; Humans; Male; Meningitis, Viral; Middle Aged; Recurrence; Valacyclovir; Valine | 2006 |
Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Janus Kinase 2; Leukemia; Male; Middle Aged; Mutation; Phenylalanine; Recurrence; Thrombocythemia, Essential; Treatment Failure; Valine | 2007 |
Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
Topics: Acyclovir; Antiviral Agents; Delivery, Obstetric; Female; Herpes Genitalis; Humans; Pregnancy; Randomized Controlled Trials as Topic; Recurrence; Valacyclovir; Valine | 2006 |
Archipelago keratitis: a clinical variant of recurrent herpetic keratitis?
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Epithelium, Corneal; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Keratitis, Herpetic; Male; Microscopy, Confocal; Middle Aged; Polymerase Chain Reaction; Pregnadienes; Recurrence; Valacyclovir; Valine | 2007 |
Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation.
Topics: Adult; Biomarkers; Computer Systems; Feasibility Studies; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Phenylalanine; Polymerase Chain Reaction; Primary Myelofibrosis; Recurrence; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous; Valine | 2007 |
Successful treatment of refractory angina pectoris due to multivessel coronary spasm with valsartan.
Topics: Aged; Angina, Unstable; Angiotensin II Type 1 Receptor Blockers; Coronary Angiography; Coronary Vasospasm; Dose-Response Relationship, Drug; Humans; Male; Recurrence; Tetrazoles; Valine; Valsartan | 2007 |
[Herpetic recurrent upper limb lymphangitis].
Topics: Acyclovir; Adult; Antiviral Agents; Female; Herpes Simplex; Humans; Lymphangitis; Prodrugs; Recurrence; Simplexvirus; Upper Extremity; Valacyclovir; Valine | 2008 |
[Herpes simplex virus meningitis in 11 patients].
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Comorbidity; Disease Susceptibility; Encephalitis, Herpes Simplex; Female; Herpes Genitalis; Herpesvirus 2, Human; Hospitals, Urban; Humans; Male; Middle Aged; Paris; Recurrence; Retrospective Studies; Treatment Outcome; Valacyclovir; Valine | 2008 |
JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.
Topics: Anemia, Sideroblastic; Humans; Janus Kinase 2; Phenylalanine; Recurrence; Thrombocytosis; Valine | 2008 |
One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Middle Aged; Pilot Projects; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Valacyclovir; Valine; Virus Cultivation; Virus Shedding | 2008 |
Beyond efficacy: new issues for HSV antiviral therapy.
Topics: Acyclovir; Antiviral Agents; Cohort Studies; Herpes Genitalis; Humans; Patient Compliance; Patient Selection; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Valacyclovir; Valine | 1997 |
Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy.
Topics: Acyclovir; Adult; Antiviral Agents; Erythema Multiforme; Humans; Male; Prodrugs; Recurrence; Time Factors; Treatment Outcome; Valacyclovir; Valine | 1998 |
[Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area].
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chemexfoliation; Chemoprevention; Dermabrasion; Dermatitis, Perioral; Elective Surgical Procedures; Famciclovir; Female; France; Herpes Simplex; Humans; Postoperative Complications; Recurrence; Stomatitis, Herpetic; Valacyclovir; Valine | 1998 |
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polymerase; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Prodrugs; Recurrence; Risk Factors; Valine | 1999 |
Valacyclovir. New indication: for genital herpes, simpler administration.
Topics: Acyclovir; Antiviral Agents; Herpes Genitalis; Humans; Recurrence; Valacyclovir; Valine | 1999 |
Relevance of Fc gamma RIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients.
Topics: Adult; Age Factors; Aged; Alleles; Amino Acid Substitution; Female; Genotype; Humans; Male; Middle Aged; Periodontitis; Phenylalanine; Polymorphism, Genetic; Receptors, IgG; Recurrence; Valine | 1999 |
Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Brain Stem; Ear; Famciclovir; Female; Herpes Genitalis; Herpesvirus 2, Human; Mice; Mice, Inbred BALB C; Recurrence; Trigeminal Ganglion; Valacyclovir; Valine | 2000 |
[Herpes genitalis].
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Famciclovir; Female; Herpes Genitalis; Humans; Male; Prevalence; Prodrugs; Recurrence; Time Factors; Valacyclovir; Valine | 1999 |
Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Disease Models, Animal; Famciclovir; Herpes Simplex; Herpesvirus 1, Human; Mice; Recurrence; Valacyclovir; Valine; Virus Latency | 2000 |
Valacyclovir hydrochloride therapy and thrombotic thrombocytopenic purpura in an HIV-infected patient.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; HIV-1; Humans; Keratitis, Herpetic; Male; Middle Aged; Prodrugs; Purpura, Thrombotic Thrombocytopenic; Recurrence; Valacyclovir; Valine | 2000 |
Recurrent herpes simplex virus infection. Suppressive, reactive, and preventive antiviral regimens.
Topics: Acyclovir; Adult; Antiviral Agents; Female; Herpes Labialis; Humans; Prodrugs; Recurrence; Valacyclovir; Valine | 2000 |
Update on antiviral therapy for genital herpes infection.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Famciclovir; Female; Herpes Genitalis; Herpes Simplex; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Valacyclovir; Valine; Virus Shedding | 2000 |
Do ACE inhibitors or ARBs limit restenosis after stenting? --assimilating the data.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Coronary Disease; Humans; Recurrence; Tetrazoles; Valine; Valsartan | 2001 |
[Recurrent corneal keratitis associated with the use of latanoprost].
Topics: Acyclovir; Administration, Oral; Adrenergic beta-Antagonists; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Glaucoma; Humans; Intestinal Absorption; Keratitis, Herpetic; Latanoprost; Prostaglandins; Prostaglandins F, Synthetic; Recurrence; Simplexvirus; Valacyclovir; Valine; Virus Activation | 2001 |
Recurrent myelitis associated with herpes simplex virus type 2.
Topics: Acyclovir; Aged; Disease Progression; Drug Therapy, Combination; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Magnetic Resonance Imaging; Myelitis; Neurologic Examination; Prednisone; Recurrence; Spinal Cord; Valacyclovir; Valine | 2001 |
A novel missense mutation in the antithrombin III gene (Ala387-->Val) causing recurrent venous thrombosis.
Topics: Adult; Alanine; Antithrombin III; Antithrombin III Deficiency; Humans; Mutation; Polymerase Chain Reaction; Recurrence; Thrombophlebitis; Valine | 1992 |